Minerva Neurosciences, Inc. Income Statement
NERV|8 years of annual SEC 10-K data (FY2017-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 8 fiscal years. All figures from audited SEC 10-K filings.
Minerva Neurosciences, Inc. reported $0 in revenue and $1M in net income for FY2024. Revenue increased 0.0% from FY2020 to FY2021.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $41.2M | $41.2M | $0 | $0 | $0 |
| SG&A Expense | $9.9M | $10.6M | $13.3M | $17.3M | $17.7M | $16.8M | $10.9M | $7.6M |
| R&D Expense | $11.9M | $14.6M | $32.0M | $22.0M | $58.1M | $34.9M | $30.3M | $18.5M |
| Operating Income | -$21.8M | -$25.2M | -$45.4M | $1.8M | -$75.9M | -$51.7M | -$41.2M | -$26.1M |
| Income Tax | - | - | -$1.8M | -$1.8M | -$2.3M | -$9.4M | -$9.4M | $0 |
| Net Income | $1.4M | -$32.1M | -$49.9M | $1.9M | -$72.2M | -$50.2M | -$31.5M | -$27.1M |
| EPS (Basic) | -$4.61 | -$6.01 | -$9.35 | $0.05 | -$1.85 | - | - | - |
| EPS (Diluted) | -$4.61 | -$6.01 | -$9.35 | $0.05 | -$1.85 | -$1.29 | -$0.83 | -$1.16 |
| Shares Outstanding | 7.0M | 5.3M | 5.3M | 42.7M | 39.1M | 38.9M | 38.7M | 35.0M |
| Operating Margin | - | - | - | 4.5% | -184.3% | - | - | - |
| Profit Margin | - | - | - | 4.7% | -175.3% | - | - | - |